COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) Fundamental Analysis & Valuation

NYSE:CRBD • US21871X2080

Current stock price

22.9 USD
-0.3 (-1.29%)
At close:
23.32 USD
+0.42 (+1.83%)
After Hours:

This CRBD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CRBD Profitability Analysis

1.1 Basic Checks

  • In the past year CRBD was profitable.
  • CRBD had a positive operating cash flow in the past year.
  • Of the past 5 years CRBD 4 years were profitable.
  • In the past 5 years CRBD always reported a positive cash flow from operatings.
CRBD Yearly Net Income VS EBIT VS OCF VS FCFCRBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

1.2 Ratios

  • CRBD has a worse Return On Assets (-0.09%) than 73.47% of its industry peers.
  • CRBD has a worse Return On Equity (-2.77%) than 75.51% of its industry peers.
  • The Return On Invested Capital of CRBD (0.17%) is worse than 66.33% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CRBD is significantly below the industry average of 8.22%.
Industry RankSector Rank
ROA -0.09%
ROE -2.77%
ROIC 0.17%
ROA(3y)0.26%
ROA(5y)0.96%
ROE(3y)8.69%
ROE(5y)28.02%
ROIC(3y)0.34%
ROIC(5y)0.97%
CRBD Yearly ROA, ROE, ROICCRBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

1.3 Margins

  • The Operating Margin of CRBD (4.92%) is worse than 61.22% of its industry peers.
  • In the last couple of years the Operating Margin of CRBD has declined.
  • CRBD does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 4.92%
PM (TTM) N/A
GM N/A
OM growth 3Y-51.36%
OM growth 5Y-12.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRBD Yearly Profit, Operating, Gross MarginsCRBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

3

2. CRBD Health Analysis

2.1 Basic Checks

  • CRBD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • CRBD has less shares outstanding than it did 1 year ago.
  • CRBD has less shares outstanding than it did 5 years ago.
  • CRBD has a better debt/assets ratio than last year.
CRBD Yearly Shares OutstandingCRBD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
CRBD Yearly Total Debt VS Total AssetsCRBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100B 200B 300B 400B

2.2 Solvency

  • CRBD has a debt to FCF ratio of 5.40. This is a neutral value as CRBD would need 5.40 years to pay back of all of its debts.
  • The Debt to FCF ratio of CRBD (5.40) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.83 indicates that CRBD is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.83, CRBD is in line with its industry, outperforming 46.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 5.4
Altman-Z N/A
ROIC/WACC0.02
WACC7.55%
CRBD Yearly LT Debt VS Equity VS FCFCRBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CRBD Yearly Current Assets VS Current LiabilitesCRBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

3

3. CRBD Growth Analysis

3.1 Past

  • CRBD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.89%.
  • The Revenue has decreased by -0.26% in the past year.
  • CRBD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.89% yearly.
EPS 1Y (TTM)-2.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.81%
Revenue 1Y (TTM)-0.26%
Revenue growth 3Y-11.53%
Revenue growth 5Y4.89%
Sales Q2Q%26.42%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.00% on average over the next years. This is quite good.
  • CRBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.21% yearly.
EPS Next Y12.16%
EPS Next 2Y13.87%
EPS Next 3Y12.08%
EPS Next 5Y12%
Revenue Next Year9.59%
Revenue Next 2Y7.58%
Revenue Next 3Y6.11%
Revenue Next 5Y6.21%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CRBD Yearly Revenue VS EstimatesCRBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B 25B
CRBD Yearly EPS VS EstimatesCRBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

8

4. CRBD Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 4.87, the valuation of CRBD can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of CRBD indicates a rather cheap valuation: CRBD is cheaper than 92.86% of the companies listed in the same industry.
  • CRBD is valuated cheaply when we compare the Price/Earnings ratio to 25.73, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 4.34, the valuation of CRBD can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBD indicates a rather cheap valuation: CRBD is cheaper than 91.84% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.72, CRBD is valued rather cheaply.
Industry RankSector Rank
PE 4.87
Fwd PE 4.34
CRBD Price Earnings VS Forward Price EarningsCRBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CRBD's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, CRBD is valued cheaply inside the industry as 90.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.46
EV/EBITDA 15.11
CRBD Per share dataCRBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • CRBD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CRBD's earnings are expected to grow with 12.08% in the coming years.
PEG (NY)0.4
PEG (5Y)N/A
EPS Next 2Y13.87%
EPS Next 3Y12.08%

3

5. CRBD Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.38%, CRBD is a good candidate for dividend investing.
  • CRBD's Dividend Yield is a higher than the industry average which is at 2.61.
  • CRBD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 4.38%

5.2 History

  • CRBD is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • CRBD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-139.62%
EPS Next 2Y13.87%
EPS Next 3Y12.08%
CRBD Yearly Income VS Free CF VS DividendCRBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

CRBD Fundamentals: All Metrics, Ratios and Statistics

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64

NYSE:CRBD (3/19/2026, 8:04:00 PM)

After market: 23.32 +0.42 (+1.83%)

22.9

-0.3 (-1.29%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)02-09
Earnings (Next)05-04
Inst Owners90.47%
Inst Owner ChangeN/A
Ins Owners0.31%
Ins Owner ChangeN/A
Market Cap11.03B
Revenue(TTM)17.80B
Net Income(TTM)-366.00M
Analysts78.1
Price Target34.38 (50.13%)
Short Float %0.01%
Short Ratio0.95
Dividend
Industry RankSector Rank
Dividend Yield 4.38%
Yearly Dividend0.97
Dividend Growth(5Y)N/A
DP-139.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.99%
Min EPS beat(2)-13.79%
Max EPS beat(2)7.82%
EPS beat(4)2
Avg EPS beat(4)2.28%
Min EPS beat(4)-13.79%
Max EPS beat(4)15.55%
EPS beat(8)6
Avg EPS beat(8)3.56%
EPS beat(12)9
Avg EPS beat(12)4.56%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)19.37%
Min Revenue beat(2)15.74%
Max Revenue beat(2)23.01%
Revenue beat(4)2
Avg Revenue beat(4)3.85%
Min Revenue beat(4)-11.92%
Max Revenue beat(4)23.01%
Revenue beat(8)3
Avg Revenue beat(8)-6.11%
Revenue beat(12)5
Avg Revenue beat(12)-5.65%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)16.22%
PT rev (3m)14.01%
EPS NQ rev (1m)-1.68%
EPS NQ rev (3m)-2.66%
EPS NY rev (1m)-1.44%
EPS NY rev (3m)-4.17%
Revenue NQ rev (1m)2.32%
Revenue NQ rev (3m)1.93%
Revenue NY rev (1m)1.37%
Revenue NY rev (3m)1.46%
Valuation
Industry RankSector Rank
PE 4.87
Fwd PE 4.34
P/S 0.62
P/FCF 5.46
P/OCF 5.46
P/B 0.84
P/tB 0.84
EV/EBITDA 15.11
EPS(TTM)4.7
EY20.52%
EPS(NY)5.27
Fwd EY23.02%
FCF(TTM)4.2
FCFY18.32%
OCF(TTM)4.2
OCFY18.32%
SpS36.95
BVpS27.41
TBVpS27.41
PEG (NY)0.4
PEG (5Y)N/A
Graham Number53.83
Profitability
Industry RankSector Rank
ROA -0.09%
ROE -2.77%
ROCE 0.21%
ROIC 0.17%
ROICexc 0.17%
ROICexgc 0.24%
OM 4.92%
PM (TTM) N/A
GM N/A
FCFM 11.35%
ROA(3y)0.26%
ROA(5y)0.96%
ROE(3y)8.69%
ROE(5y)28.02%
ROIC(3y)0.34%
ROIC(5y)0.97%
ROICexc(3y)0.34%
ROICexc(5y)0.97%
ROICexgc(3y)0.5%
ROICexgc(5y)1.47%
ROCE(3y)0.43%
ROCE(5y)1.25%
ROICexgc growth 3Y-59.3%
ROICexgc growth 5Y-9.14%
ROICexc growth 3Y-58.91%
ROICexc growth 5Y-8.46%
OM growth 3Y-51.36%
OM growth 5Y-12.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.83
Debt/FCF 5.4
Debt/EBITDA 7.62
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.5
Cash Conversion 141.13%
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.55%
ROIC/WACC0.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-0.81%
EPS Next Y12.16%
EPS Next 2Y13.87%
EPS Next 3Y12.08%
EPS Next 5Y12%
Revenue 1Y (TTM)-0.26%
Revenue growth 3Y-11.53%
Revenue growth 5Y4.89%
Sales Q2Q%26.42%
Revenue Next Year9.59%
Revenue Next 2Y7.58%
Revenue Next 3Y6.11%
Revenue Next 5Y6.21%
EBIT growth 1Y-72.38%
EBIT growth 3Y-56.97%
EBIT growth 5Y-8.3%
EBIT Next Year33.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.04%
FCF growth 3Y-9.15%
FCF growth 5Y-9.49%
OCF growth 1Y-6.04%
OCF growth 3Y-9.15%
OCF growth 5Y-9.49%

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 / CRBD Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64?

ChartMill assigns a fundamental rating of 3 / 10 to CRBD.


What is the valuation status of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

ChartMill assigns a valuation rating of 8 / 10 to COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD). This can be considered as Undervalued.


What is the profitability of CRBD stock?

COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) has a profitability rating of 2 / 10.


What is the valuation of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 based on its PE and PB ratios?

The Price/Earnings (PE) ratio for COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is 4.87 and the Price/Book (PB) ratio is 0.84.


What is the financial health of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) stock?

The financial health rating of COREBRIDGE FINANCIAL INC - CRBG 6 3/8 12/15/64 (CRBD) is 3 / 10.